39th Pharmacovigilance India 2025

“Ensuring safer drugs to market”

19th - 20th November 2025,  Hotel Kohinoor Continental, Mumbai, India

Virtue Insight is proud to announce 39th Pharmacovigilance 2025, 19th - 20th November 2025, Hotel Kohinoor Continental, Mumbai, India.

 

Sponsor / Delegate Registration E-mail - kavitha@virtueinsight.co.in or M: +91 9361957193   

SPONSORS:

Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries

DELEGATE REGISTRATION:

Exclusive Offer — 3 Delegates for the Price of 2! (For the first 50 bookings only)

 

Super Early Bird Price (Valid until 26^th Sep) - INR 16,000 + GST per delegate

Early Bird Price (Valid from 27^th Sep - 31^st Oct ) - INR 18,000 + GST per delegate

 

Standard Price (Valid from 1^st Nov)  - INR 21,000 + GST per delegate

 

KEY SPEAKERS:

SOMNATH BASU, Team Leader Reviewers of Drugs, National Regulatory Authority for Drugs (NRA India)

MAYUR PARMAR, Drugs Inspector (Deputy Collector, Gujarat Government), FDA

KHAUDEJA BANO, Vice President Combination Product Quality, Amgen (USA)

RAJ K BHOGAL, Sr. Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals (UK)

PRASAD DESHMUKH, Vice President & Head Pharmacovigilance, Cipla

PRATIK SHAH, Vice President Medical Affairs, Bharat Serums and Vaccines

VIPIN SETHI, VP International Business, Head Global PV Function, Cadila

RAHUL GUPTA, Vice President, Regulatory Affairs, USV

MILIND ANTANI, Leader, Pharma & Healthcare, Nishith Desai Associates
GEETA SHANBHAG, VP - PV & Medico-Regulatory Affairs, Ipca Laboratories

SANTOSH TAUR, Director Medical Affairs, Ex-Chair, RWE Council, ISCR, Pfizer

VAIBHAV SALVI, Director & Head - Clinical Study Unit, India & South East Asia, Sanofi

PRABHAT SINHA, Director Government & Public Affairs, Boehringer Ingelheim

RISHI JAIN, Country Medical Head, Novartis

SHIRAZ KANDAWALLA, Associate Director, Ferring Pharmaceuticals

SAKSHI SHRIVASTAVA DESAI, Associate Director International PV Strategy Realization, Johnson & Johnson

MUKESH GORI, Associate Director -ESP Management CMO & PS, Novartis

INDU NAMBIAR, Pharmacovigilance Lead & Country Safety Head, Sanofi

SOURABH FULMALI, Global Medical Director – Respiratory, GSK

ROHINI PANDEY, Regional PV Head- SEA, Abbott

HARSHAD MALVE, Medical Head - Self-Care & Operations, Kenvue

JYOTSNA PATWARDHAN, Cluster Head Clinical/PV QA at Africa, Middle East, Turkey & India, Novartis
DHWANI DHOLAKIA, Division Head - Information Technology, Otsuka Pharmaceutical

JAMAL BAIG, Multi Country Safety Head, Sanofi
RENUKA NEOGI, Head & Deputy GM – Global Clinical Quality Management, Sun Pharma

SADANAND KULKARNI, Head- Medical, Regulatory, Vigilance & Quality, Fresenius Kabi

JEROZE DALAL, Head of Clinical Operations, Governance & Risk Management, GSK

MAYUR MAYBHATE, Head Medical Affairs, Alkem Laboratories

KRUNAL DALAL, Head Medical Affairs, GSK

RAHUL SOMANI, Head- Global Pharmacovigilance, Alkem Laboratories

APARNA PRABHUNE, Assistant General Manager – Regulatory Affairs, Wockhardt

VYNIE ANN RAO, Drug Safety & Risk Management Manager, Lupin

SUCHITA MORE, Associate Director Medical Affairs, MSD

CHITRA BARGAJE, Sr.GM, Global Head PV, Drug Safety & Risk Management, Lupin
GIRISH SANE, GM & Head Pharmacovigilance, Bristol Laboratories

KAVITA LAMROR, Partner, RWE & Digital Transformation, Maxis Clinical Sciences

SHRADDHA BHANGE, Senior Medical Safety Lead, Sandoz

KHOKAN DEBNATH, Sr. GM - Regulatory Affairs, Clinical Operations, PV & QA, Wockhardt

BIJENDER MISHRA, Sr. GM & CISO, Alkem Laboratories
RASHMI HEGDE, Former Executive Vice President Medical Affairs, GSK

JOYDEEP SENGUPTA, Global Pharmacovigilance - Site Head, Sun Pharmaceuticals

MARTINA GOMES, Head, Reg Affairs – CH, South Asia, Bayer

ANUJA JAWALE, Associate Director - RA/PV Strategic Engagements & Vendor Management, Organon

MEERA NAGARIA, Senior Data Scientist, Johnson & Johnson (Boston, USA)
SOUVIK CHATTERJEE, Senior Global Auditor, Novartis

MUGDHA SHAH, PV Audit and Inspection Readiness Manager, Sanofi

JYOTI KASHID, Manager, Global Patient Safety Operations, Lundbeck (Singapore)

VANSHIKA BRIJWANI, Manager Country Development Quality (CDQ), Novartis

KUSHAL SARDA, GM & Head - Medical Affairs, Clinical Research & PV, Shalina Healthcare

CHAITANYA KULKARNI, GM Pharmacovigilance, Marksans Pharma

VISHWAS SOVANI, Founder Director, Pharmawisdom

Plus more joining soon

FOCUSED AREAS:

Market Trends - Critiques & Ways Forward

Challenges / Opportunities

Patient Safety / Patient Centricity

RMP

Quality

Safety & Signal Detection

Automation in PV

Regulatory

Impact of Technology AI, ML

Audits & Inspection

RWE / RWD

Outsourcing

WHO SHOULD ATTEND & WHO YOU’LL MEET:

CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from the following areas:

Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and Clinical Data Management, Clinical Research, Research & Development, Product Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data Analysis, Epidemiology project management, Regulatory Affairs and Compliance, Sales & Marketing, Biotech manufacturers

From the following:

Pharmaceutical organizations, Generic pharmaceutical companies, Contract research organizations, Patient recruitment companies

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.